117 related articles for article (PubMed ID: 28559931)
1. Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15-34 years of age: a prospective cohort study.
Samuelsson M; Dereke J; Svensson MK; Landin-Olsson M; Hillman M;
Diabetol Metab Syndr; 2017; 9():41. PubMed ID: 28559931
[TBL] [Abstract][Full Text] [Related]
2. HbA1c levels and circulating inflammatory proteins at onset of type 1 diabetes in children and adolescents.
Dereke J; Nilsson C
J Diabetes Metab Disord; 2022 Dec; 21(2):1427-1432. PubMed ID: 36404844
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 and CD163 as Potential Biomarkers to Differentiate Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome.
Gao Z; Wang Y; Wang J; Zhang J; Wang Z
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019008. PubMed ID: 30671214
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD163 was linked to galectin-3, diabetic retinopathy and antidepressants in type 1 diabetes.
Melin EO; Dereke J; Thunander M; Hillman M
Endocr Connect; 2018 Dec; 7(12):1343-1353. PubMed ID: 30400063
[TBL] [Abstract][Full Text] [Related]
5. Relationship between soluble protein ST2 (sST2) levels and microvascular complications in a cohort of patients with type 1 diabetes.
Forga L; López-Andrés N; Tamayo I; Fernández-Celis A; García-Mouriz M; Goñi MJ
Endocrinol Diabetes Nutr (Engl Ed); 2021 Jul; ():. PubMed ID: 34274305
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
Greisen SR; Møller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Junker P; Østergaard M; Hvid M; Deleuran B
Clin Exp Rheumatol; 2015; 33(4):498-502. PubMed ID: 25962601
[TBL] [Abstract][Full Text] [Related]
7. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance.
Dereke J; Nilsson J; Nilsson C; Strevens H; Landin-Olsson M; Hillman M
PLoS One; 2019; 14(5):e0216728. PubMed ID: 31071174
[TBL] [Abstract][Full Text] [Related]
9. Distribution and clinical association of plasma soluble ST2 during the development of type 2 diabetes.
Lin YH; Zhang RC; Hou LB; Wang KJ; Ye ZN; Huang T; Zhang J; Chen X; Kang JS
Diabetes Res Clin Pract; 2016 Aug; 118():140-5. PubMed ID: 27371779
[TBL] [Abstract][Full Text] [Related]
10. Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis.
Willems S; Quax PH; de Borst GJ; de Vries JP; Moll FL; de Kleijn DP; Hoefer IE; Pasterkamp G
Atherosclerosis; 2013 Nov; 231(1):48-53. PubMed ID: 24125409
[TBL] [Abstract][Full Text] [Related]
11. A study of diabetes complications in an endogamous population: an emerging public health burden.
Bener A; Al-Laftah F; Al-Hamaq AO; Daghash M; Abdullatef WK
Diabetes Metab Syndr; 2014; 8(2):108-14. PubMed ID: 24907176
[TBL] [Abstract][Full Text] [Related]
12. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV
J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410
[TBL] [Abstract][Full Text] [Related]
13. Temporal changes of soluble ST2 after cardiovascular interventions.
Willems S; Sels JW; Flier S; Versteeg D; Buhre WF; de Kleijn DP; Hoefer IE; Pasterkamp G
Eur J Clin Invest; 2013 Feb; 43(2):113-20. PubMed ID: 23215810
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
15. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis.
Greisen SR; Moller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Jørgensen A; Hvid M; Deleuran B
Clin Exp Rheumatol; 2011; 29(4):689-92. PubMed ID: 21813065
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
Deichgræber P; Witte DR; Møller HJ; Skriver MV; Richelsen B; Jørgensen ME; Johansen NB; Sandbæk A
Diabetologia; 2016 Nov; 59(11):2467-2476. PubMed ID: 27541014
[TBL] [Abstract][Full Text] [Related]
17. Soluble ST2 is a biomarker for cardiovascular mortality related to abnormal glucose metabolism in high-risk subjects.
Cardellini M; Rizza S; Casagrande V; Cardolini I; Ballanti M; Davato F; Porzio O; Canale MP; Legramante JM; Mavilio M; Menghini R; Martelli E; Farcomeni A; Federici M
Acta Diabetol; 2019 Mar; 56(3):273-280. PubMed ID: 30259114
[TBL] [Abstract][Full Text] [Related]
18. Regular Training Increases sTWEAK and Its Decoy Receptor sCD163-Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
Schönbauer R; Lichtenauer M; Paar V; Emich M; Fritzer-Szekeres M; Schukro C; Strametz-Juranek J; Sponder M
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32560548
[TBL] [Abstract][Full Text] [Related]
19. Serum soluble CD163 predicts risk of type 2 diabetes in the general population.
Møller HJ; Frikke-Schmidt R; Moestrup SK; Nordestgaard BG; Tybjærg-Hansen A
Clin Chem; 2011 Feb; 57(2):291-7. PubMed ID: 21106861
[TBL] [Abstract][Full Text] [Related]
20. Increased soluble ST2 and IL‑4 serum levels are associated with disease severity in patients with membranous nephropathy.
Zhang Z; Liu X; Wang H; Qu Z; Crew R; Zhang N; Jiang Y
Mol Med Rep; 2018 Feb; 17(2):2778-2786. PubMed ID: 29207152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
